Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 726,305 shares at $0.15 ($109K) on 2011-09-29, disclosed to the SEC on 2011-09-30.
Open-market sale of $109k ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.15 | 10,000 | $2K | 1.4% |
| 2 | $0.15 | 108,080 | $16K | 14.9% |
| 3 | $0.15 | 608,225 | $91K | 83.7% |
| Total | $0.15 avg | 726,305 | $109K | 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |